The recently created Spanish healthcare company ADL Bionatur Solutions SA has raised €12 million in a share placement with institutional investors to support the development of products for human and animal health.
The company is the result of a reverse acquisition of Bionaturis, a biotech company, by ADL Biopharma, a contract manufacturer, and is listed on the Mercado Alternativo Bursátil, the junior market of the Spanish securities market.